Showing 1381-1390 of 10594 results for "".
Looking Back at the First Successful Human Organ Transplant
https://reachmd.com/programs/inspired-to-act/looking-back-at-the-first-successful-human-organ-transplant/4138/Nobel Prize winner Dr. Joseph E. Murray discusses performing the first successful human kidney transplant, the value of teamwork, the future of the physician-scientist, and the patient side of the equation, in this far-ranging conversation led by host Dr. Martin Samuels.Carved in Sand
https://reachmd.com/programs/clinicians-roundtable/carved-in-sand/3222/Anyone older than forty knows that forgetfulness can be unnerving, frustrating and sometimes terrifying. Investigative journalist Cathryn Jakobson Ramin embarked on a three year journey to revive her brain using the latest that science has to offer. She joins host Dr. Leslie Lundt to discuss what sBrain Response to Psychotherapy
https://reachmd.com/programs/clinicians-roundtable/brain-response-to-psychotherapy/2062/We discuss endlessly the different mechanisms of actions of psychotropic meds – but what does psychotherapy do in the brain? Emory University psychiatrist, Dr. Boadie Dunlop, joins host Dr. Leslie Lundt to discuss the biology of psychotherapy.Diabetes and Physical Fitness
https://reachmd.com/programs/focus-on-diabetes/diabetes-and-physical-fitness/1917/We all know that exercise is crucial in the successful management of diabetes. But how do you actually get patients to do it? Certified diabetes educator Jeanne Diaz, certified diabetes educator and personal trainer, provides practical tips as she discusses diabetes fitness with host Dr. Leslie LunDoes a Prodrome exist in Bipolar Disorder?
https://reachmd.com/programs/clinicians-roundtable/does-a-prodrome-exist-in-bipolar-disorder/1649/Is there an identifiable clinical prodrome that precedes development of full bipolar disorder? Host Dr. Leslie Lundt welcomes Dr. Christoph Correll to discuss early identification of children and adolescents with bipolar disorder.The Biology and Course of Malarial Disease
https://reachmd.com/programs/clinicians-roundtable/the-biology-and-course-of-malarial-disease/648/In this segment, Dr. Plowe describes the pertinent biological features of malarial infection and the scope of malaria's impact on a global level. Many physicians are surprised to learn that between one and three million people continue to die each year secondary to this disease. The interview revisiHow Insulin Kills: Forensic Insights from the Legendary Claus von Bülow Case
https://reachmd.com/programs/clinicians-roundtable/how-insulin-kills-forensic-insights-from-the-legendary-claus-von-bulow-case/569/Dr. Vincent Marks describes the pathophysiology of how insulin could be used as a potential murder weapon. He also comments on the famous Claus von Bülow case, where an overdose of insulin was suspected and made the subject of national news. As an expert witness in that case, Dr. Marks provided keyNeighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
https://reachmd.com/programs/clinicians-roundtable/neighborhood-archetypes-patient-outcomes-pediatric-all-aml/54351/Emerging research suggests that neighborhood archetypes are significantly associated with survival in children and young adults with acute leukemia. In this conversation with Dr. Charles Turck, Dr. Lena Winestone shares findings from a population-based study of nearly 9,000 patients with acute lymphOctane Aesthetics Tech Forum: Structural Adipose Tissue is Next Frontier
https://reachmd.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-structural-adipose-tissue-is-next-frontier/54707/At the 2026 Octane Aesthetics Tech Forum, Christopher Khorsandi, MD, board-certified plastic surgeon, and Chief Medical Officer of Tiger Aesthetics, joined the “Future of Aesthetics” panel to discuss what’s next for the field. In this video interview, he explains why structural adipose tissue couldCurative Strategies for Sickle Cell Disease: The Future of Gene Editing
https://reachmd.com/programs/project-oncology/curative-strategies-for-sickle-cell-disease-the-future-of-gene-editing/36489/With two FDA-approved gene therapies, including the first CRISPR-based treatment, curative strategies for sickle cell disease are continuing to expand the treatment landscape. However, challenges remain in optimizing safety and accessibility, particularly for patients unable to tolerate current myel